Polymer nanoparticles mediated codelivery of AntimiR-10b and AntimiR-21 for achieving triple negative breast cancer therapy

ACS Nano

Volumn 9, Issue 3, 2015, Pages 2290-2302

  Devulapally, Rammohan ^a   Sekar, Narayana M ^a   Sekar, Thillai V ^a   Foygel, Kira ^a   Massoud, Tarik F ^a   Willmann, Jürgen K ^a   Paulmurugan, Ramasamy ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

anti miRs; antisense miRNAs; bioluminescence; cancer therapy; in vivo molecular imaging; microRNA; nanoparticles; PLGA; targeted delivery

Indexed keywords

BIOLUMINESCENCE; CONJUGATED POLYMERS; DISEASES; MAMMALS; MOLECULAR IMAGING; NANOPARTICLES; ONCOLOGY; PATHOLOGY; RNA; TUMORS;

ANTI-MIRS; ANTISENSE; CANCER THERAPY; IN-VIVO; MICRORNAS; PLGA; TARGETED DELIVERY;

FUNCTIONAL POLYMERS;

DRUG CARRIER; MACROGOL DERIVATIVE; MICRORNA; MIRN10 MICRORNA, HUMAN; MIRN21 MICRORNA, HUMAN; POLY(LACTIC-GLYCOLIC ACID)-POLY(ETHYLENEGLYCOL) COPOLYMER; POLYGLACTIN; UROKINASE RECEPTOR;

ANIMAL; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; CHEMISTRY; DRUG EFFECTS; FEMALE; GENE THERAPY; GENETICS; HUMAN; METABOLISM; METASTASIS; MOUSE; NANOMEDICINE; PATHOLOGY; PROCEDURES; RNA STABILITY; TRANSPORT AT THE CELLULAR LEVEL; TRIPLE NEGATIVE BREAST NEOPLASMS; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; DRUG CARRIERS; FEMALE; GENETIC THERAPY; HUMANS; MICE; MICRORNAS; NANOMEDICINE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; POLYETHYLENE GLYCOLS; POLYGLACTIN 910; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; RNA STABILITY; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84925637860     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn507465d     Document Type: Article

References (46)

1. Akao, Y.; Nakagawa, Y.; Hirata, I.; Iio, A.; Itoh, T.; Kojima, K.; Nakashima, R.; Kitade, Y.; Naoe, T. Role of Anti-Oncomirs MiR-143 and -145 in Human Colorectal Tumors Cancer Gene Ther. 2010, 17, 398-408
2. Esquela-Kerscher, A.; Slack, F. J. Oncomirs-MicroRNAs with a Role in Cancer Nat. Rev. Cancer 2006, 6, 259-269
3. Kitade, Y.; Akao, Y. MicroRNAs and Their Therapeutic Potential for Human Diseases: MicroRNAs, MiR-143 and -145, Function as Anti-Oncomirs and the Application of Chemically Modified MiR-143 as an Anti-Cancer Drug J. Pharmacol Sci. 2010, 114, 276-280
4. Krutovskikh, V. A.; Herceg, Z. Oncogenic MicroRNAs (Oncomirs) as a New Class of Cancer Biomarkers Bioessays 2010, 32, 894-904
5. Reshmi, G.; Pillai, M. R. Beyond HPV: Oncomirs as New Players in Cervical Cancer FEBS Lett. 2008, 582, 4113-4116
6. Kota, J.; Chivukula, R. R.; ODonnell, K. A.; Wentzel, E. A.; Montgomery, C. L.; Hwang, H. W.; Chang, T. C.; Vivekanandan, P.; Torbenson, M.; Clark, K. R. et al. Therapeutic MicroRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model Cell 2009, 137, 1005-1017
7. Liu, C.; Kelnar, K.; Liu, B.; Chen, X.; Calhoun-Davis, T.; Li, H.; Patrawala, L.; Yan, H.; Jeter, C.; Honorio, S. et al. The MicroRNA MiR-34a Inhibits Prostate Cancer Stem Cells and Metastasis by Directly Repressing CD44 Nat. Med. 2011, 17, 211-215
8. Krutzfeldt, J.; Rajewsky, N.; Braich, R.; Rajeev, K. G.; Tuschl, T.; Manoharan, M.; Stoffel, M. Silencing of MicroRNAs In Vivo with Antagomirs Nature 2005, 438, 685-689
9. Ross, J. S.; Carlson, J. A.; Brock, G. Mirna: The New Gene Silencer Am. J. Clin Pathol 2007, 128, 830-836
10. De Palma, M.; Naldini, L. Antagonizing Metastasis Nat. Biotechnol. 2010, 28, 331-332
11. Ma, L.; Reinhardt, F.; Pan, E.; Soutschek, J.; Bhat, B.; Marcusson, E. G.; Teruya-Feldstein, J.; Bell, G. W.; Weinberg, R. A. Therapeutic Silencing of MiR-10b Inhibits Metastasis in a Mouse Mammary Tumor Model Nat. Biotechnol. 2010, 28, 341-347
12. Asangani, I. A.; Rasheed, S. A.; Nikolova, D. A.; Leupold, J. H.; Colburn, N. H.; Post, S.; Allgayer, H. MicroRNA-21 (MiR-21) Post-Transcriptionally Downregulates Tumor Suppressor Pdcd4 and Stimulates Invasion, Intravasation and Metastasis in Colorectal Cancer Oncogene 2008, 27, 2128-2136
13. Chan, J. A.; Krichevsky, A. M.; Kosik, K. S. MicroRNA-21 is an Antiapoptotic Factor in Human Glioblastoma Cells Cancer Res. 2005, 65, 6029-6033
14. Cheng, A. M.; Byrom, M. W.; Shelton, J.; Ford, L. P. Antisense Inhibition of Human MiRNAs and Indications for an Involvement of MiRNA in Cell Growth and Apoptosis Nucleic Acids Res. 2005, 33, 1290-1297
15. Loffler, D.; Brocke-Heidrich, K.; Pfeifer, G.; Stocsits, C.; Hackermuller, J.; Kretzschmar, A. K.; Burger, R.; Gramatzki, M.; Blumert, C.; Bauer, K. et al. Interleukin-6 Dependent Survival of Multiple Myeloma Cells Involves the Stat3-Mediated Induction of MicroRNA-21 through a Highly Conserved Enhancer Blood 2007, 110, 1330-1333
16. Papagiannakopoulos, T.; Shapiro, A.; Kosik, K. S. MicroRNA-21 Targets a Network of Key Tumor-Suppressive Pathways in Glioblastoma Cells Cancer Res. 2008, 68, 8164-8172
17. Zhang, Z.; Li, Z.; Gao, C.; Chen, P.; Chen, J.; Liu, W.; Xiao, S.; Lu, H. MiR-21 Plays a Pivotal Role in Gastric Cancer Pathogenesis and Progression Lab. Invest. 2008, 88, 1358-1366
18. Zhu, S.; Wu, H.; Wu, F.; Nie, D.; Sheng, S.; Mo, Y. Y. MicroRNA-21 Targets Tumor Suppressor Genes in Invasion and Metastasis Cell Res. 2008, 18, 350-359
19. Su, J.; Baigude, H.; McCarroll, J.; Rana, T. M. Silencing MicroRNA by Interfering Nanoparticles in Mice Nucleic Acids Res. 2011, 39, e38
20. Huang, X.; Schwind, S.; Yu, B.; Santhanam, R.; Wang, H.; Hoellerbauer, P.; Mims, A.; Klisovic, R.; Walker, A. R.; Chan, K. K. et al. Targeted Delivery of MicroRNA-29b by Transferrin-Conjugated Anionic Lipopolyplex Nanoparticles: A Novel Therapeutic Strategy in Acute Myeloid Leukemia Clin. Cancer Res. 2013, 19, 2355-2367
21. Ashley, C. E.; Carnes, E. C.; Phillips, G. K.; Padilla, D.; Durfee, P. N.; Brown, P. A.; Hanna, T. N.; Liu, J. W.; Phillips, B.; Carter, M. B. et al. The Targeted Delivery of Multicomponent Cargos to Cancer Cells by Nanoporous Particle-Supported Lipid Bilayers Nat. Mater. 2011, 10, 389-397
22. Devulapally, R.; Paulmurugan, R. Polymer Nanoparticles for Drug and Small Silencing RNA Delivery to Treat Cancers of Different Phenotypes Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 2014, 6, 40-60
23. Abeylath, S. C.; Ganta, S.; Iyer, A. K.; Amiji, M. Combinatorial-Designed Multifunctional Polymeric Nanosystems for Tumor-Targeted Therapeutic Delivery Acc. Chem. Res. 2011, 44, 1009-1017
24. Fattal, E.; Barratt, G. Nanotechnologies and Controlled Release Systems for the Delivery of Antisense Oligonucleotides and Small Interfering RNA Br. J. Pharmacol. 2009, 157, 179-194
25. Babar, I. A.; Cheng, C. J.; Booth, C. J.; Liang, X.; Weidhaas, J. B.; Saltzman, W. M.; Slack, F. J. Nanoparticle-Based Therapy in an In Vivo MicroRNA-155 (miR-155)-Dependent Mouse Model of Lymphoma Proc. Natl. Acad. Sci. U. S. A. 2012, 109, E1695-E1704
26. Ren, Y.; Kang, C. S.; Yuan, X. B.; Zhou, X.; Xu, P.; Han, L.; Wang, G. X.; Jia, Z.; Zhong, Y.; Yu, S. et al. Co-Delivery of As-miR-21 and 5-FU by Poly(amidoamine) Dendrimer Attenuates Human Glioma Cell Growth In Vitro J. Biomater. Sci., Polym. Ed. 2010, 21, 303-314
27. Wu, Y.; Crawford, M.; Mao, Y.; Lee, R. J.; Davis, I. C.; Elton, T. S.; Lee, L. J.; Nana-Sinkam, S. P. Therapeutic Delivery of MicroRNA-29b by Cationic Lipoplexes for Lung Cancer Mol. Ther.-Nucleic Acids 2013, 2, e84
28. Jin, H.; Yu, Y.; Chrisler, W. B.; Xiong, Y.; Hu, D.; Lei, C. Delivery of MicroRNA-10b with Polylysine Nanoparticles for Inhibition of Breast Cancer Cell Wound Healing Breast Cancer 2012, 6, 9-19
29. Pecot, C. V.; Calin, G. A.; Coleman, R. L.; Lopez-Berestein, G.; Sood, A. K. RNA Interference in the Clinic: Challenges and Future Directions Nat. Rev. Cancer 2011, 11, 59-67
30. Fernandez-Fernandez, A.; Manchanda, R.; McGoron, A. J. Theranostic Applications of Nanomaterials in Cancer: Drug Delivery, Image-Guided Therapy, and Multifunctional Platforms Appl. Biochem. Biotechnol. 2011, 165, 1628-1651
31. Lu, J. M.; Wang, X.; Marin-Muller, C.; Wang, H.; Lin, P. H.; Yao, Q.; Chen, C. Current Advances in Research and Clinical Applications of PLGA-Based Nanotechnology Expert Rev. Mol. Diagn. 2009, 9, 325-341
32. Mundargi, R. C.; Babu, V. R.; Rangaswamy, V.; Patel, P.; Aminabhavi, T. M. Nano/Micro Technologies for Delivering Macromolecular Therapeutics Using Poly(d, l -Lactide-Co-Glycolide) and Its Derivatives J. Controlled Release 2008, 125, 193-209
33. Harris, J. M.; Chess, R. B. Effect of Pegylation on Pharmaceuticals Nat. Rev. Drug Discovery 2003, 2, 214-221
34. Schmidts, T.; Dobler, D.; Nissing, C.; Runkel, F. Influence of Hydrophilic Surfactants on the Properties of Multiple W/O/W Emulsions J. Colloid Interface Sci. 2009, 338, 184-192
35. Woodrow, K. A.; Cu, Y.; Booth, C. J.; Saucier-Sawyer, J. K.; Wood, M. J.; Saltzman, W. M. Intravaginal Gene Silencing Using Biodegradable Polymer Nanoparticles Densely Loaded with Small-Interfering RNA Nat. Mater. 2009, 8, 526-533
36. Paulmurugan, R.; Sekar, N. M.; Sekar, T. V. Biodegradable Polymer Nanocarriers for Therapeutic Antisense MicroRNA Delivery in Living Animals Proc. SPIE 2012, 8232, 823208
37. Cao, M.; Deng, X.; Su, S.; Zhang, F.; Xiao, X.; Hu, Q.; Fu, Y.; Yang, B. B.; Wu, Y.; Sheng, W. et al. Protamine Sulfate-Nanodiamond Hybrid Nanoparticles as a Vector for MiR-203 Restoration in Esophageal Carcinoma Cells Nanoscale 2013, 5, 12120-12125
38. Mitchell, P. S.; Parkin, R. K.; Kroh, E. M.; Fritz, B. R.; Wyman, S. K.; Pogosova-Agadjanyan, E. L.; Peterson, A.; Noteboom, J.; OBriant, K. C.; Allen, A. et al. Circulating MicroRNAs as Stable Blood-Based Markers for Cancer Detection Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 10513-10518
39. Ma, L. Role of MiR-10b in Breast Cancer Metastasis Breast Cancer Res. 2010, 12, 210
40. Ma, L.; Teruya-Feldstein, J.; Weinberg, R. A. Tumour Invasion and Metastasis Initiated by MicroRNA-10b in Breast Cancer Nature 2007, 449, 682-688
41. Sekar, T. V.; Mohanram, R. K.; Foygel, K.; Paulmurugan, R. Therapeutic Evaluation of MicroRNAs by Molecular Imaging Theranostics 2013, 3, 964-985
42. Cheng, C. J.; Saltzman, W. M. Polymer Nanoparticle-Mediated Delivery of MicroRNA Inhibition and Alternative Splicing Mol. Pharmaceutics 2012, 9, 1481-1488
43. Iyevleva, A. G.; Kuligina, E.; Mitiushkina, N. V.; Togo, A. V.; Miki, Y.; Imyanitov, E. N. High Level of MiR-21, MiR-10b, and MiR-31 Expression in Bilateral vs. Unilateral Breast Carcinomas Breast Cancer Res. Treat. 2012, 131, 1049-59
44. Yan, L. X.; Wu, Q. N.; Zhang, Y.; Li, Y. Y.; Liao, D. Z.; Hou, J. H.; Fu, J.; Zeng, M. S.; Yun, J. P.; Wu, Q. L. et al. Knockdown of MiR-21 in Human Breast Cancer Cell Lines Inhibits Proliferation, In Vitro Migration and In Vivo Tumor Growth Breast Cancer Res. 2011, 13, R2
45. Ulisse, S.; Baldini, E.; Sorrenti, S.; DArmiento, M. The Urokinase Plasminogen Activator System: A Target for Anti-Aancer Therapy Curr. Cancer Drug Targets 2009, 9, 32-71
46. Gu, F.; Langer, R.; Farokhzad, O. Formulation/Preparation of Functionalized Nanoparticles for In Vivo Targeted Drug Delivery. In Micro and Nano Technologies in Bioanalysis; Foote, R. S.; Lee, J. W., Eds.; Humana Press: New York, 2009; Vol. 544, pp 589-598.